(Q31135530)

https://api.crossref.org/works/10.1023/A:1015836720294

28 November 2022

pharmaceutical science

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1023/A:1015836720294

28 November 2022

1 reference

https://api.crossref.org/works/10.1023/A:1015836720294

28 November 2022

1 reference

https://api.crossref.org/works/10.1023/A:1015836720294

28 November 2022

1 reference

https://api.crossref.org/works/10.1023/A:1015836720294

28 November 2022

author name string

J. Mordenti

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1798669

1

1 reference

28 November 2022

S. A. Chen

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1798669

2

1 reference

28 November 2022

J. A. Moore

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1798669

3

1 reference

28 November 2022

B. L. Ferraiolo

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1798669

4

1 reference

28 November 2022

J. D. Green

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1798669

5

1 reference

28 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

PubMed ID

1798669

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1798669

The CD4 antigen: physiological ligand and HIV receptor

28 November 2022

publication date

1 November 1991

1 reference

29 June 2017

Pharmaceutical Research

1 reference

29 June 2017

8

1 reference

29 June 2017

1351-1359

1 reference

29 June 2017

11

1 reference

29 June 2017

1 reference

12 December 2020

[Determination of the antiactivator activity in human and animal blood plasma using tissue plasminogen activator]

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of a human relaxin in the mouse pubic symphysis bioassay

1 reference

12 December 2020

Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.

1 reference

12 December 2020

Biological properties of a CD4 immunoadhesin

1 reference

12 December 2020

Characterization studies of human tissue-type plasminogen activator produced by recombinant DNA technology

1 reference

12 December 2020

Accessories or coreceptors?

1 reference

12 December 2020

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

12 December 2020

Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm

1 reference

12 December 2020

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

12 December 2020

Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects

1 reference

12 December 2020

Equivalent potency and pharmacokinetics of recombinant human growth hormones with or without an N-terminal methionine

1 reference

12 December 2020

Renal extraction, filtration, absorption, and catabolism of growth hormone

1 reference

12 December 2020

The influence of carbohydrate structure on the clearance of recombinant tissue-type plasminogen activator

1 reference

12 December 2020

Characterization of a soluble form of human CD4. Peptide analyses confirm the expected amino acid sequence, identify glycosylation sites and demonstrate the presence of three disulfide bonds

1 reference

12 December 2020

Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

1 reference

12 December 2020

Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver

1 reference

12 December 2020

The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.

1 reference

12 December 2020

Purification and characterization of a melanoma cell plasminogen activator

1 reference

12 December 2020

Carbohydrate structures of recombinant soluble human CD4 expressed in Chinese hamster ovary cells

1 reference

12 December 2020

Designing CD4 immunoadhesins for AIDS therapy

1 reference

12 December 2020

A specific growth hormone-binding protein in human plasma: initial characterization

1 reference

12 December 2020

Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4.

1 reference

12 December 2020

Isolation, identification and pharmacokinetic properties of human tissue-type plasminogen activator species: possible localisation of a clearance recognition site

1 reference

12 December 2020

Plasminogen activator inhibitors

1 reference

12 December 2020

Cellular catabolism of recombinant tissue-type plasminogen activator. Identification and characterization of a novel high affinity uptake system on rat hepatocytes

1 reference

12 December 2020

The circulating growth hormone (GH)-binding protein complex: a major constituent of plasma GH in man

1 reference

12 December 2020

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

1 reference

12 December 2020

The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone

1 reference

12 December 2020

Disposition of a novel recombinant tissue plasminogen activator, delta 2-89 TPA, in mice

1 reference

12 December 2020

Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to benzodiazepines and phenytoin

1 reference

12 December 2020

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

1 reference

12 December 2020

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

1 reference

12 December 2020

Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial

1 reference

12 December 2020

Structural characterization of a recombinant CD4-IgG hybrid molecule

1 reference

12 December 2020

Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion

1 reference

12 December 2020

The rabbit as a model for studies of fibrinolysis

1 reference

12 December 2020

Identification and characterization of specific binding proteins for growth hormone in normal human sera

1 reference

12 December 2020

Uptake and degradation of tissue plasminogen activator in rat liver

1 reference

12 December 2020

Identifiers

DOI